title: Antibody-dependent cell-mediated cytotoxicity in simian immunodeficiency virus-infected rhesus monkeys.
abstract: With the recent demonstration in the RV144 Thai trial that a vaccine regimen that does not elicit neutralizing antibodies or cytotoxic T lymphocytes may confer protection against human immunodeficiency virus type 1 (HIV-1) infection, attention has turned to nonneutralizing antibodies as a possible mechanism of vaccine protection. In the current study, we evaluated the kinetics of the antibody-dependent cell-mediated cytotoxicity (ADCC) response during acute and chronic SIVmac251 infection of rhesus monkeys. We first adapted a flow cytometry-based ADCC assay, evaluating the use of different target cells as well as different strategies for quantitation of activated natural killer (NK) cells. We found that the use of SIVmac251 Env gp130-coated target cells facilitates analyses of ADCC activity with a higher degree of sensitivity than the use of simian immunodeficiency virus (SIV)-infected target cells; however, the kinetics of the measured responses were the same using these different target cells. By comparing NK cell expression of CD107a with NK cell expression of other cytokines or chemokine molecules, we found that measuring CD107a expression is sufficient for evaluating the anti-SIV function of NK cells. We also showed that ADCC responses can be detected as early as 3 weeks after SIVmac251 infection and that the magnitude of this antibody response is inversely associated with plasma viral RNA levels in animals with moderate to high levels of viral replication. However, we also demonstrated an association between NK cell-mediated ADCC responses and the amount of SIVmac251 gp140 binding antibody that developed after viral infection. This final observation raises the possibility that the antibodies that mediate ADCC are a subset of the antibodies detected in a binding assay and arise within weeks of infection.
authors: Division of Viral Pathogenesis, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Center for Life Science, 330 Brookline Avenue, Boston, MA 02115, USA.
authors: Yue
authors: Y
authors: Sun
authors: Mohammed
authors: M
authors: Asmal
authors: Sophie
authors: S
authors: Lane
authors: Sallie R
authors: SR
authors: Permar
authors: Stephen D
authors: SD
authors: Schmidt
authors: John R
authors: JR
authors: Mascola
authors: Norman L
authors: NL
authors: Letvin
references: Leukemia. 2007 Feb;21(2):356-9; author reply 359
references: 17251901
references: Curr Opin HIV AIDS. 2009 Sep;4(5):388-93
references: 20048702
references: J Immunol Methods. 2006 Jan 20;308(1-2):53-67
references: 16343526
references: J Virol. 2008 Jun;82(11):5450-9
references: 18353957
references: AIDS. 2009 May 15;23(8):897-906
references: 19414990
references: J Virol. 1999 Nov;73(11):8966-74
references: 10516002
references: J Virol. 1989 Feb;63(2):584-90
references: 2536094
references: Nat Rev Immunol. 2005 Nov;5(11):835-43
references: 16239902
references: J Immunol. 2006 Sep 15;177(6):3848-56
references: 16951347
references: J Virol. 2009 Sep;83(17):8705-12
references: 19553339
references: J Virol. 2001 Aug;75(15):6953-61
references: 11435575
references: Annu Rev Immunol. 2010;28:413-44
references: 20192810
references: J Clin Immunol. 2001 May;21(3):227-33
references: 11403230
references: Science. 2010 Aug 13;329(5993):856-61
references: 20616233
references: Blood. 2006 Jun 1;107(11):4466-74
references: 16469871
references: J Virol. 2006 Jun;80(12):6177-81
references: 16731957
references: J Immunol. 2008 Sep 1;181(5):3643-50
references: 18714039
references: J Virol. 1998 Mar;72(3):1886-93
references: 9499040
references: N Engl J Med. 2009 Dec 3;361(23):2209-20
references: 19843557
references: J Virol. 2011 Jun;85(11):5465-75
references: 21450829
references: J Immunol. 1996 Sep 1;157(5):2168-73
references: 8757343
references: Nature. 2007 Sep 6;449(7158):101-4
references: 17805298
references: J Virol. 2010 Aug;84(16):8209-18
references: 20519381
references: J Virol. 2007 Aug;81(15):8009-15
references: 17522197
references: Virology. 2000 Apr 25;270(1):237-49
references: 10772996
references: J Virol. 2006 Sep;80(18):9217-25
references: 16940533